Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

The CD40/CD154 receptor/ligand dyad.

Schönbeck U, Libby P.

Cell Mol Life Sci. 2001 Jan;58(1):4-43. Review.

PMID:
11229815
2.

CD40 signaling and plaque instability.

Schönbeck U, Libby P.

Circ Res. 2001 Dec 7;89(12):1092-103. Review.

3.

Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.

Howard LM, Miller SD.

Autoimmunity. 2004 Aug;37(5):411-8. Review.

PMID:
15621565
4.

Immune regulation by CD40-CD40-l interactions - 2; Y2K update.

van Kooten C.

Front Biosci. 2000 Nov 1;5:D880-693. Review.

PMID:
11056083
5.

The role of CD40-CD154 interaction in cell immunoregulation.

Xu Y, Song G.

J Biomed Sci. 2004 Jul-Aug;11(4):426-38. Review.

PMID:
15153777
6.

The CD40-CD154 interaction in B cell-T cell liaisons.

Bishop GA, Hostager BS.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):297-309. Review.

PMID:
12787567
7.

CD40 and tolerance induction.

Karimi MH, Pourfathollah AA.

Iran J Allergy Asthma Immunol. 2012 Mar;11(1):1-13. doi: 011.01/ijaai.113. Review.

8.

Prospects for CD40-directed experimental therapy of human cancer.

Tong AW, Stone MJ.

Cancer Gene Ther. 2003 Jan;10(1):1-13. Review.

PMID:
12489023
9.

CD40 and dendritic cell function.

O'Sullivan B, Thomas R.

Crit Rev Immunol. 2003;23(1-2):83-107. Review.

PMID:
12906261
10.

CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.

Chen K, Huang J, Gong W, Zhang L, Yu P, Wang JM.

Cell Mol Immunol. 2006 Jun;3(3):163-9. Review.

11.

Regulation of CD40 ligand expression in systemic lupus erythematosus.

Crow MK, Kirou KA.

Curr Opin Rheumatol. 2001 Sep;13(5):361-9. Review.

PMID:
11604589
12.

CD40/CD40L signaling and its implication in health and disease.

Chatzigeorgiou A, Lyberi M, Chatzilymperis G, Nezos A, Kamper E.

Biofactors. 2009 Nov-Dec;35(6):474-83. doi: 10.1002/biof.62. Review.

PMID:
19904719
13.

The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.

Engel D, Seijkens T, Poggi M, Sanati M, Thevissen L, Beckers L, Wijnands E, Lievens D, Lutgens E.

Semin Immunol. 2009 Oct;21(5):308-12. doi: 10.1016/j.smim.2009.06.004. Epub 2009 Jul 17. Review.

PMID:
19616449
14.

Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection.

Denton MD, Reul RM, Dharnidharka VR, Fang JC, Ganz P, Briscoe DM.

Pediatr Transplant. 1998 Feb;2(1):6-15. Review.

PMID:
10084754
15.

Tuning of CD40-CD154 interactions in human B-lymphocyte activation: a broad array of in vitro models for a complex in vivo situation.

Néron S, Nadeau PJ, Darveau A, Leblanc JF.

Arch Immunol Ther Exp (Warsz). 2011 Feb;59(1):25-40. doi: 10.1007/s00005-010-0108-8. Epub 2011 Jan 14. Review.

PMID:
21234809
16.

Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.

Dejica DI, Manea EM.

Roum Arch Microbiol Immunol. 2006 Jan-Jun;65(1-2):66-74. Review.

PMID:
17877113
17.

The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.

Toubi E, Shoenfeld Y.

Autoimmunity. 2004 Sep-Nov;37(6-7):457-64. Review.

PMID:
15621572
18.

Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease.

Danese S, Fiocchi C.

Crit Rev Immunol. 2005;25(2):103-21. Review.

PMID:
15952932
19.

CD154 and its receptors in inflammatory vascular pathologies.

Hassan GS, Merhi Y, Mourad WM.

Trends Immunol. 2009 Apr;30(4):165-72. doi: 10.1016/j.it.2009.01.004. Epub 2009 Mar 11. Review.

PMID:
19282242
20.

CD40-CD154 interaction in experimental and human disease (review).

Biancone L, Cantaluppi V, Camussi G.

Int J Mol Med. 1999 Apr;3(4):343-53. Review.

PMID:
10085405

Supplemental Content

Support Center